Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 17/20 | 0.52 |
| ▸ | MITF | O75030 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | PER2 | O15055 | 1/20 | 0.49 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.49 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28701935 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL29558821 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL30145482 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL30145458 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL17147695 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL17147693 | 1.00 | DNM1 (0.52) | DNM1MITFALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL17147690 | 0.85 | PER2 (0.53) | PER2CRY1CRY2 | |
| SCHEMBL17147692 | 0.85 | PER2 (0.53) | PER2CRY1CRY2 | |
| SCHEMBL17147694 | 0.85 | PER2 (0.53) | PER2CRY1CRY2 | |
| SCHEMBL29558339 | 0.85 | PER2 (0.53) | PER2CRY1CRY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110003172-B | Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators | 同步制药公司 | 2022-04-01 | — | — | CN | disclosed |